Clinical-stage biotech possibly nearing phase I completion
Updated
Nascent Biotech is reportedly closing in on phase I trial completion. I am interested to see if it pulls back and how it interacts with the moving averages.
nascentbiotech.com/nascent-biotech-completes-third-cohort-in-phase-1-human-trial-for-primary-and-metastatic-brain-cancer/
nascentbiotech.com/nascent-biotech-completes-third-cohort-in-phase-1-human-trial-for-primary-and-metastatic-brain-cancer/
Note
As you can see, the move went higher briefly and eventually landed right around where I started. I made this a while back and had taken all the profit. It was a stage 1 trial so just potential was needed. It is easier to track a stage 1 through the trials and likely get a rise in price. But this is long since over and I do am not recommending the stock by any means. If you do see this, then always read as much as you can about the company's current work.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.